Bieche I, Parfait B, Tozlu S, Lidereau Roentgen, Vidaud Meters: Quantitation of androgen receptor gene term during the sporadic nipple tumors of the real-time RT-PCR: research you to MYC is a keen AR-regulated gene. Carcinogenesis. 2001, twenty two (9): 1521-1526. /carcin/22.9.1521.
Bratthauer GL, Lininger RA, Kid YG, Tavassoli FA: Androgen and you may the hormone estrogen receptor mRNA position into the apocrine carcinomas. Diagn Mol Pathol. 2002, 11 (2): 113-118. 9606-200206000-00008.
Gatalica Z: Immunohistochemical data off apocrine nipple sores. Consistent more than-phrase regarding androgen receptor followed by the increased loss of the hormone estrogen and progesterone receptors during the apocrine metaplasia and you can apocrine carcinoma in the situ. Pathol Res Pract. 1997, 193 (11-12): 753-758.
Was J Clin Pathol
Soreide JA, Lea OA, Varhaug JE, Skarstein A good, Kvinnsland S: Androgen receptors when you look at the operable breast cancer: reference to almost every other steroid hormone receptors, correlations to help you prognostic things and you may predictive really worth to have effect of adjuvant tamoxifen therapy. Eur J Surg Oncol. 1992, 18 (2): 112-118.
Bayer-Garner IB, Smoller B: Androgen receptors: a great marker to increase sensitiveness to own distinguishing breast cancer when you look at the skin metastasis away from unknown pri, 13 (2): 119-122. /modpathol.3880021.
Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic craft and you will clinical ramifications. J Clin Oncol. 2000, 18 (5): 1135-1149.
Pang ST, Flores-Morales A beneficial, Skoog L, Chuan YC, Nordstedt Grams, Pousette A good: Control of matrix metalloproteinase thirteen term by the androgen from inside the prostate disease. Oncol Rep. 2004, eleven (6): 1187-1192.
Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ: Androgen receptors in breast cancer. Cancer. 1984, 54 (11): 2436-2440. -0142(19841201)<2436::AID-CNCR2820541121>3.0.
Schippinger W, Regitnig P, Dandachi Letter, Wernecke KD, Bauernhofer T, Samonigg H, Moinfar F: Evaluation of the prognostic need for androgen receptor expression into the metastatic breast cancer. Virchows Arch. 2006, 449 (1): 24-29. /s00428-00six-0213-six.
Parker RL, Huntsman DG, Lesack DW, Cupples JB, Give DR, Akbari Meters, Gilks CB: Review out of interlaboratory version throughout the immunohistochemical commitment out of the hormone estrogen receptor position using a cancer of the breast structure microarray. 2002, 117 (5): 723-728. /PEF8-GL6F-YWMC-AG56.
Vizoso FJ, Gonzalez LO, Corte MD, Rodriguez JC, Vazquez J, Lamelas ML, , Garcia-Muniz JL: Examination of matrix metalloproteinases as well as their inhibitors in breast cancer. Br J Cancer. 2007, 96 (6): 903-911. /sj.bjc.6603666.
Narita D, Raica M, Suciu C, Cimpean An effective, Anghel A great: Immunohistochemical term from androgen receptor and prostate-certain antigen inside the cancer of the breast. Folia Histochem Cytobiol. 2006, forty two (3): 165-172.
Egeblad Meters, Werb Z: Brand new properties on matrix metalloproteinases when you look at the cancers progression. Nat Rev Malignant tumors. 2002, 2 (3): 161-174. /nrc745.
Turk V, Kos J, Turk B: Cysteine cathepsins (proteases)–toward fundamental phase of cancer?. Disease Telephone. 2004, 5 (5): 409-410. /S1535-6108(04)00117-5.
Manes S, Llorente M, Lacalle RA, Gomez-Mouton C, Kremer L, Mira E, Martinez Air conditioning: The fresh matrix metalloproteinase-nine handles the new insulin-like development factor-triggered autocrine impulse from inside the DU-145 carcinoma tissue. J Biol Chem. 1999, 274 (11): 6935-6945. /jbc..
Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel Meters: Release of an invasion promoter Age-cadherin fragment from the matrilysin and stromelysin-step one. J Mobile Sci. 2001 www.datingranking.net/tr/older-women-dating-inceleme, 114 (Pt 1): 111-118.
Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM: Matrilysin [MMP-7] expression chooses to own cells with minimal sensitiveness so you can apoptosis. Neoplasia. 2001, step 3 (6): 459-468. /sj.neo.7900190.
CO;2-H
Stetler-Stevenson WG: Matrix metalloproteinases from inside the angiogenesis: a relocation target to have healing intervention. J Clin Purchase. 1999, 103 (9): 1237-1241. /JCI6870.
Cornelius Los angeles, Nehring LC, Harding Elizabeth, Bolanowski M, Welgus HG, Kobayashi DK, Penetrate RA, Shapiro SD: Matrix metalloproteinases generate angiostatin: outcomes with the neovascularization. J Immunol. 1998, 161 (12): 6845-6852.
Jiang Y, Goldberg ID, Shi YE: Complex jobs out-of structure inhibitors away from metalloproteinases inside the cancer tumors. Oncogene. 2002, 21 (14): 2245-2252. /sj.onc.1205291.